Contact

Invitation: Live Presentation with CEO Richard Paxman – Year-end report 2025

PAXMAN will publish its interim report for the fourth quarter of 2025 on 27 February at 07:00 CET. A live presentation for investors, analysts and media will be held later the same morning at 09:00 CET.

During the presentation, CEO Richard Paxman will comment on the report. The Q&A session will be moderated by Maria Karlsson Osipova, Equity Research Analyst at Carnegie. The presentation will be held in English.

Register here: https://qcnl.tv/p/f_GeFg5hcn5YgVViQctckQ

What we do
Paxman are world leaders in chemotherapy side effect management on an ambitious journey to change the face of cancer through cryotherapy-based treatments. The Paxman mission is to democratise access to scalp cooling globally.
Learn more →
Financial Information
Read the latest Paxman financial reports. In these comprehensive documents, you will find a detailed overview of our financial performance, key milestones, and a strategic outlook for the future. Reports are published quarterly and annually.
Read reports  →
Investing in Paxman
Paxman has treated 100,000+ patients and installed 5,000+ systems in more than 65 countries worldwide. We are helping to manage the trauma of chemotherapy hair loss. By investing in Paxman, you're not just supporting a company; you're joining us in changing the face of cancer.
Visit the Investor Centre →
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram